Which preventive care is due for her?

AKAnna Keller, 47 · Hypertension, prediabetes, LDL 162 mg/dl · 14 documents, read 16 September 2026

Answered on 16 September 2026

Matched against the German screening programme, the STIKO schedule and the guidelines, as of today:

Consider: lipoprotein(a), once. Eur Heart J Visit 12.05.2026
Consider: coronary calcium scan as a risk modifier before long-term statin therapy, if desired. Eur Heart J
Due: tetanus-diphtheria booster (last 2015; every ten years). Impfpass 2015 STIKO
Already addressed: HbA1c (May 2026), check-up (May 2026), cervical screening co-test (June 2024, next 2027), abdominal ultrasound (May 2026). Lab 08.05.2026 Check-up 12.05.2026 Gyn 03.06.2024 Ultrasound 12.05.2026
Missing information: date of the last dental check-up not documented. Intake 20.09.2023
Not yet due: mammography screening from 50; colorectal screening from 50 (stool test) or 55 (colonoscopy). G-BA
Not routinely indicated: whole-body MRI; resting ECG without symptoms. Eur Heart J DEGAM

Two of these fit into today's visit: the booster can be given now, and lipoprotein(a) goes on the next laboratory order. Visit 16.09.2026

From the patient record8 of 14 documents

Visit note, check-up discussion, 12 May 2026Clinical note
Vaccination record, tetanus and diphtheria 2015, August 2015Vaccination record
Laboratory report, 8 May 2026Laboratory
Check-up (Gesundheitsuntersuchung) documentation, SCORE2, 12 May 2026Check-up
Gynaecology report, cervical screening, 3 June 2024External report
Abdominal ultrasound report, 12 May 2026Imaging
Intake interview, history and family history, 20 September 2023Anamnesis
Visit note, today's consultation (draft), 16 September 2026Clinical note

1.Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement.European Heart Journal. 2022;43:3925-3946. Kronenberg F, Mora S, Stroes ESG, et al.Guideline
2.2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.European Heart Journal. 2021;42:3227-3337. Visseren FLJ, Mach F, Smulders YM, et al.Guideline
SummaryRisk estimation with SCORE2 (40 to 69 years) and SCORE2-OP; risk modifiers include a family history of premature cardiovascular disease, lipoprotein(a), coronary artery calcium and psychosocial stress. In apparently healthy people at low-to-moderate risk, lipid-lowering treatment should be considered when LDL cholesterol stays at or above 2.6 mmol/l (100 mg/dl) after lifestyle intervention; a stepwise approach with treatment targets by risk category.
Source
Issuing body: European Society of Cardiology
Published: September 2021
Grading system: ESC classes of recommendation I–III, levels of evidence A–C
Scope
Target population: Apparently healthy people and patients with established disease
Scope: Risk assessment, lifestyle, lipids, blood pressure, diabetes
3.Impfkalender: Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut.Robert Koch-Institut. Current version. Programme
4.Früherkennung bei Erwachsenen.Gemeinsamer Bundesausschuss. Current version. Programme
5.S3-Leitlinie Hausärztliche Risikoberatung zur kardiovaskulären Prävention (AWMF-Registernummer 053-024).Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin. Current version. Guideline

What would you like to ask next?

1Which screenings are already complete, and when were they done?2Which findings were never followed up?

This is a sample workspace. Click one of the questions. To ask your own questions, request access.

Anna Keller, 47Mosaic